Skip to main content

Table 3 Serum metabolites of RA EP patients

From: Serum metabolomics analysis of deficiency pattern and excess pattern in patients with rheumatoid arthritis

No.

Metabolite

m/z

RT (min)

Formula

VIP

Fold Change

Trend

1

Gamma-Aminobutyric acid

104.11

8.16

C4H9NO2

2.56

-2.28

2

 L-Homocysteic acid

184.07

8.01

C4H9NO5S

4.74

-2.72

3

 S-Nitrosoglutathione

337.06

0.62

C10H16N4O7S

10.03

2044.09

4

LysoPA(18:1(9Z)/0:0)

459.25

8.01

C21H41O7P

1.01

-2.12

5

LysoPE(P-16:0/0:0)

438.30

8.35

C21H44NO6P

1.40

-2.47

6

LysoPC(16:0/0:0)

496.34

8.16

C24H50NO7P

38.02

-2.29

7

LysoPC(P-18:0/0:0)

508.38

8.55

C26H54NO6P

3.19

-2.96

8

DG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

685.44

11.50

C43H66O5

1.24

3.42

9

Bisdiphosphoinositol tetrakisphosphate

820.81

0.55

C6H20O30P8

1.24

2.67

10

PE(22:0/24:0)

888.80

0.55

C51H102NO8P

1.36

2.56

11

PC(24:0/24:1(15Z))

956.79

0.55

C56H110NO8P

1.29

2.36

12

Pyruvic acid

174.96

0.49

C3H4O3

4.84

15.21

13

D-Ribose

130.97

0.49

C5H10O5

2.13

9.07

14

 L-Targinine

187.07

0.60

C7H16N4O2

1.68

53.79

15

 N(omega)-Hydroxyarginine

224.98

0.63

C6H14N4O3

1.26

-9.13

16

Citric acid

191.02

0.64

C6H8O7

2.66

6.12

17

Gamma-Glutamylserine

269.08

0.60

C8H14N2O6

4.21

52.50

18

5-Thymidylic acid

357.03

0.63

C10H15N2O8P

3.53

2.17

19

Inosinic acid

329.04

0.59

C10H13N4O8P

5.62

124.17

20

SN38 glucuronide

549.05

0.64

C28H28N2O11

1.14

15.33

21

PC(O-22:1(13Z)/22:3(10Z,13Z,16Z))

878.77

0.48

C52H98NO7P

1.63

4.20

22

PE(22:0/24:1(15Z))

866.78

0.53

C51H100NO8P

1.91

3.57

23

Octanoyl-CoA

874.24

0.48

C29H50N7O17P3S

1.21

3.57

24

PC(24:0/24:0)

1002.76

0.53

C56H112NO8P

1.30

2.14

  1. Fold change refers to the “RA EP group vs. healthy group” change value
  2. LysoPA Lysophosphatidic acid, LysoPE Lysophosphatidylethanolamine, LysoPC Lysophosphatidylcholine, DG Diacyl glycerol, PE Phosphatidylethanolamine, PC Phosphatidylcholine